Aviva PLC Johnson & Johnson Transaction History

Aviva PLC

$34.3 Billion
Q2 2024

A detailed history of Aviva PLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aviva PLC holds 1,493,496 shares of JNJ stock, worth $234 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

1,493,496

Previous 1,239,699 20.47%

Holding current value

$234 Million

Previous $196 Million 11.31%

% of portfolio

0.64%

Previous 0.69%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$144.38 - $157.78 $36.6 Million - $40 Million	253,797 Added 20.47%	1,493,496 $218 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $3.88 Million - $4.06 Million	24,966 Added 2.06%	1,239,699 $196 Million
Q4 2023 Feb 09, 2024	BUY	$145.6 - $158.88 $16.4 Million - $17.9 Million	112,877 Added 10.24%	1,214,733 $190 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $13.4 Million - $15 Million	-85,828 Reduced 7.23%	1,101,856 $172 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $35.7 Million - $38.4 Million	231,184 Added 24.17%	1,187,684 $197 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $4.24 Million - $5.06 Million	-28,085 Reduced 2.85%	956,500 $148 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $26 Million - $29.2 Million	162,472 Added 19.76%	984,585 $174 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $6.28 Million - $6.98 Million	-38,904 Reduced 4.52%	822,113 $134 Million
Q2 2022 Aug 04, 2022	BUY	$168.19 - $186.01 $20.7 Million - $22.8 Million	122,803 Added 16.64%	861,017 $153 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $18.9 Million - $21.4 Million	-119,430 Reduced 13.93%	738,214 $131 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $12.7 Million - $14.1 Million	-81,477 Reduced 8.68%	857,644 $147 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $11.5 Million - $12.8 Million	-71,155 Reduced 7.04%	939,121 $152 Million
Q2 2021 Aug 10, 2021	BUY	$159.48 - $171.07 $2.25 Million - $2.42 Million	14,138 Added 1.42%	1,010,276 $166 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $3.36 Million - $3.74 Million	21,920 Added 2.25%	996,138 $164 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $1.26 Million - $1.44 Million	9,156 Added 0.95%	974,218 $153 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $4.94 Million - $5.41 Million	-35,178 Reduced 3.52%	965,062 $144 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $5.16 Million - $6.23 Million	-40,080 Reduced 3.85%	1,000,240 $141 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $76,019 - $105,329	-684 Reduced 0.07%	1,040,320 $136 Million
Q4 2019 Feb 10, 2020	SELL	$127.5 - $146.44 $160,140 - $183,928	-1,256 Reduced 0.12%	1,041,004 $152 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $13 Million - $14.6 Million	-102,645 Reduced 8.97%	1,042,260 $135 Million
Q2 2019 Jul 30, 2019	SELL	$131.15 - $144.24 $4.87 Million - $5.35 Million	-37,115 Reduced 3.14%	1,144,905 $159 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $353,776 - $393,369	2,814 Added 0.24%	1,182,020 $165 Million
Q4 2018 Feb 12, 2019	SELL	$122.84 - $147.84 $38.9 Million - $46.9 Million	-316,955 Reduced 21.18%	1,179,206 $152 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $8.18 Million - $9.62 Million	-67,318 Reduced 4.31%	1,496,161 $207 Million
Q2 2018 Aug 01, 2018	SELL	$119.4 - $131.76 $2.44 Million - $2.69 Million	-20,446 Reduced 1.29%	1,563,479 $190 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $16.2 Million - $19.2 Million	-129,859 Reduced 7.58%	1,583,925 $203 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $28.4 Million - $31.1 Million	-216,383 Reduced 11.21%	1,713,784 $239 Million
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $1.79 Million - $1.87 Million	-13,802 Reduced 0.71%	1,930,167 $251 Million
Q2 2017 Aug 07, 2017	BUY	N/A	1,943,969	1,943,969 $257 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account